Abstract
Developments in high-throughput genotyping have progressed to the point where genome-wide association studies are becoming practical. Multistage designs involving large numbers of sequence variants (∼300,000) and relatively large samples sizes (several hundred cases and control subjects) will be essential to reliably detect alleles with appreciable effect sizes (2-fold increase in relative risk). Direct sequencing of candidate genes in cases and control subjects provides an alternative approach that can reveal low-frequency alleles that influence disease susceptibility. Ultimately, the outcome of both approaches will depend on the genetic architecture of coronary heart disease.
Original language | English (US) |
---|---|
Pages (from-to) | A10-A14 |
Journal | Journal of the American College of Cardiology |
Volume | 48 |
Issue number | 9 SUPPL. |
DOIs | |
State | Published - Nov 7 2006 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine